Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. DFTX
10. NAVN

Go back to Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

Vericel Corporation (VCEL) PT Lowered to $45 at BTIG

February 24, 2022 12:54 PM EST

BTIG analyst Ryan Zimmerman lowered the price target on Vericel Corporation (NASDAQ: VCEL) to $45.00 (from $50.00) while maintaining a Buy rating.

The analyst commented, "We maintain our Buy rating but lower our PT to $45 (from $50) as multiples have compressed in high-growth MedTech. VCEL reported 4Q21 revenue of $47.6M (+5.2% Y/Y) which was below BTIG/Consensus original expectations of $50.7M/$51.0M with the... More